Live from the NIH registry
Studies recruiting near Provo right now
Top 25 of 119 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Utah Valley Regional Medical Center — Provo, Utah (1.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — West Jordan, Utah (29.5 mi)
· Sponsor: AstraZeneca
Healing ALS Registry Observational Study (HAROS)
Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND)
N/A
Observational 1,000 participants sought
Virtual — Park City, Utah (28.7 mi)
· Sponsor: Healing Advocates Registry and Ministry
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
South Jordan Health Center — South Jordan, Utah (26.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
Pneumonia
N/A
Interventional 4,000 participants sought
Utah Valley Instacare — Provo, Utah (1.1 mi)
· Sponsor: Intermountain Health Care, Inc.
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Jordan Valley Dermatology Center — South Jordan, Utah (26.5 mi)
· Sponsor: Incyte Corporation
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
South Jordan Health Center — South Jordan, Utah (26.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
Salt Lake Retina (01044) — West Jordan, Utah (29.5 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
South Jordan Health Center — South Jordan, Utah (26.5 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
Pneumococcal Disease
Phase 3
Interventional 1,200 participants sought
AMR Clinical — Provo, Utah (1.1 mi)
· Sponsor: Pfizer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Utah Valley Regional Medical Center — Provo, Utah (1.1 mi)
· Sponsor: NRG Oncology
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Alopecia Areata
Phase 2
Interventional 60 participants sought
Jordan Valley Dermatology & Research Center — South Jordan, Utah (26.5 mi)
· Sponsor: Eli Lilly and Company
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Springville Dermatology - Springville- Site Number : 8400055 — Springville, Utah (5.9 mi)
· Sponsor: Sanofi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Utah Valley Regional Medical Center — Provo, Utah (1.1 mi)
· Sponsor: NRG Oncology
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
Extubation Failure, Bronchopulmonary Dysplasia
N/A
Interventional 478 participants sought
Utah Valley Hospital — Provo, Utah (1.1 mi)
· Sponsor: University of Pennsylvania
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Diabetes & Endocrine Treatment Specialists — Sandy City, Utah (27.0 mi)
· Sponsor: Zucara Therapeutics Inc.
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Osteoarthritis, Overweight or Obesity
Phase 3
Interventional 900 participants sought
AMR Clinical — South Jordan, Utah (26.5 mi)
· Sponsor: Eli Lilly and Company
Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease
Peyronie Disease
Phase 4
Interventional 40 participants sought
Male Fertility and Peyronie's Clinic — Orem, Utah (4.4 mi)
· Sponsor: Charitable Union for the Research and Education of Peyronie's Disease
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Agitation, Alzheimer Disease
Phase 2
Interventional 120 participants sought
Boeson Research - Provo — Provo, Utah (1.1 mi)
· Sponsor: Celgene
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 980 participants sought
Velocity Clinical Research, Salt Lake City - Site Number: 8400147 — West Jordan, Utah (29.5 mi)
· Sponsor: Sanofi
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Major Depressive Episode (MDE), Major Depressive Disorder (MDD)
Phase 2
Interventional 360 participants sought
Boeson Research Pvu — Provo, Utah (1.1 mi)
· Sponsor: Tonix Pharmaceuticals, Inc.
Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry
Otitis Media With Effusion, Acute Otitis Media
N/A
Observational 200 participants sought
Peak Pediatric Ear, Nose and Throat — Provo, Utah (1.1 mi)
· Sponsor: Smith & Nephew, Inc.
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Acute Ischemic Stroke
Phase 4
Interventional 500 participants sought
Route 92 Medical, Inc. — West Jordan, Utah (29.5 mi)
· Sponsor: Route 92 Medical, Inc.
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
Arrhythmia
N/A
Observational 500 participants sought
Cardio Surgical Partners, LLC — Lehi, Utah (14.8 mi)
· Sponsor: QuesGen Systems Inc
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Chronic Spontaneous Urticaria (CSU)
Phase 3
Interventional 400 participants sought
Allergy Associates of Utah — Sandy City, Utah (27.0 mi)
· Sponsor: Novartis Pharmaceuticals